Montelukast Sodium Market: How Is the Generic Landscape Reshaping the Leukotriene Antagonist Market?
The global respiratory and allergic disease pharmacological treatment landscape in 2026 includes a substantial and mature market for montelukast sodium, with the Montelukast Sodium Market reflecting the post-patent generic market dynamics of one of the most widely prescribed leukotriene receptor antagonist medications globally, where loss of the original Singulair branded product exclusivity...
0 Comentários 0 Compartilhamentos 46 Visualizações 0 Anterior